Hinge Health's New Products, Margin Gains Support Growth Outlook, RBC Says

MT Newswires Live06-11

Hinge Health (HNGE) has a "long runway" for growth driven by new products, expanding market opportunities and continued margin improvement, RBC Capital Markets said in a report emailed Thursday, following the company's Movement 2026 conference and investor session in Chicago.

The firm highlighted Hinge Health's decision to raise its Q2 and full-year 2026 guidance, citing strong performance in April and May and management's confidence in the business through the remainder of the year. The company also introduced a "target operating model" that calls for 20% to 25% revenue growth and operating margins above 35%, which the analysts said were "achievable over the medium-term."

Hinge Health could further expand its addressable market through new offerings, including HingeSelect Surgery and its Migraine program. The migraine offering has already been adopted by 300 clients covering more than 3 million "contracted lives" and represents a potential $25 billion annual market opportunity, according to the report.

RBC maintained an outperform rating on Hinge Health and raised the price target to $75 from $65.

Price: 64.79, Change: +2.73, Percent Change: +4.40

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2642387512?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 23:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2642387512","market":"nz","top_or_hot":-1,"title":"Hinge Health's New Products, Margin Gains Support Growth Outlook, RBC Says","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/HNGE\">Hinge Health</a> (HNGE) has a \"long runway\" for growth driven by new products, expanding market opportunities and continued margin improvement, RBC Capital Markets said in a report emailed Thursday, following the company's Movement 2026 conference and investor session in Chicago.</p><p>The firm highlighted Hinge Health's decision to raise its Q2 and full-year 2026 guidance, citing strong performance in April and May and management's confidence in the business through the remainder of the year. The company also introduced a \"target operating model\" that calls for 20% to 25% revenue growth and operating margins above 35%, which the analysts said were \"achievable over the medium-term.\"</p><p>Hinge Health could further expand its addressable market through new offerings, including HingeSelect Surgery and its Migraine program. The migraine offering has already been adopted by 300 clients covering more than 3 million \"contracted lives\" and represents a potential $25 billion annual market opportunity, according to the report.</p><p>RBC maintained an outperform rating on Hinge Health and raised the price target to $75 from $65.</p><p>Price: 64.79, Change: +2.73, Percent Change: +4.40</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hinge Health's New Products, Margin Gains Support Growth Outlook, RBC Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHinge Health's New Products, Margin Gains Support Growth Outlook, RBC Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-11 23:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/HNGE\">Hinge Health</a> (HNGE) has a \"long runway\" for growth driven by new products, expanding market opportunities and continued margin improvement, RBC Capital Markets said in a report emailed Thursday, following the company's Movement 2026 conference and investor session in Chicago.</p><p>The firm highlighted Hinge Health's decision to raise its Q2 and full-year 2026 guidance, citing strong performance in April and May and management's confidence in the business through the remainder of the year. The company also introduced a \"target operating model\" that calls for 20% to 25% revenue growth and operating margins above 35%, which the analysts said were \"achievable over the medium-term.\"</p><p>Hinge Health could further expand its addressable market through new offerings, including HingeSelect Surgery and its Migraine program. The migraine offering has already been adopted by 300 clients covering more than 3 million \"contracted lives\" and represents a potential $25 billion annual market opportunity, according to the report.</p><p>RBC maintained an outperform rating on Hinge Health and raised the price target to $75 from $65.</p><p>Price: 64.79, Change: +2.73, Percent Change: +4.40</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2642387512","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2642387512","pubTimestamp":1781190766,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Hinge Health  has a \"long runway\" for growth driven by new products, expanding market opportunities and continued margin improvement, RBC Capital Markets said in a report emailed Thursday, following the company's Movement 2026 conference and investor session in Chicago.The firm highlighted Hinge Health's decision to raise its Q2 and full-year 2026 guidance, citing strong performance in April and May and management's confidence in the business through the remainder of the year. The company also introduced a \"target operating model\" that calls for 20% to 25% revenue growth and operating margins above 35%, which the analysts said were \"achievable over the medium-term.\"Hinge Health could further expand its addressable market through new offerings, including HingeSelect Surgery and its Migraine program. The migraine offering has already been adopted by 300 clients covering more than 3 million \"contracted lives\" and represents a potential $25 billion annual market opportunity, according to t","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","HNGE":"Hinge Health, Inc."},"translate_title":"加拿大皇家银行表示，Hinge Health的新产品和利润率增长支持增长前景","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HNGE":1.5},"content_text":"Hinge Health (HNGE) has a \"long runway\" for growth driven by new products, expanding market opportunities and continued margin improvement, RBC Capital Markets said in a report emailed Thursday, following the company's Movement 2026 conference and investor session in Chicago.The firm highlighted Hinge Health's decision to raise its Q2 and full-year 2026 guidance, citing strong performance in April and May and management's confidence in the business through the remainder of the year. The company also introduced a \"target operating model\" that calls for 20% to 25% revenue growth and operating margins above 35%, which the analysts said were \"achievable over the medium-term.\"Hinge Health could further expand its addressable market through new offerings, including HingeSelect Surgery and its Migraine program. The migraine offering has already been adopted by 300 clients covering more than 3 million \"contracted lives\" and represents a potential $25 billion annual market opportunity, according to the report.RBC maintained an outperform rating on Hinge Health and raised the price target to $75 from $65.Price: 64.79, Change: +2.73, Percent Change: +4.40","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2642387512","isCrawlerRequest":true}